NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/06/2026
Voltar para busca
Dado oficial do USPTO
RECURSION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
56
Atualização mais recente
30/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
30/11/2022
Data de registro
30/06/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/06/2026
Última transação
30/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
16/11/2013
Primeiro uso no comércio
16/11/2013
Código do desenho
4
Tipo de titular
03
Localização do titular
Salt Lake City, UT, US
Examinador
PEREZ, STEVEN M
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Recursion Pharmaceuticals, Inc.
Representantes
David P. Johnson WORKMAN NYDEGGER
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Providing temporary use of onlinenon-downloadable computer software for data processing for use in diagnosing medical conditionsprescribing medical treatment and prescriptionsdesigning clinical trials and forecasting clinical trial resultssearching for clinical trial patientsanalyzing medical imagesanalyzing datadeveloping pharmaceutical products and chemical compoundsperforming pharmaceutical research and developmentperforming scientific research and development of pharmaceutical preparationsdeveloping new uses for pharmaceutical compounds through the use of computer modelsanimal modelscontrolled environmentsfor use in contract research services in support of scientific research and development of pharmaceutical preparationsfor providing technical consultancy and services in relation to technical research in the field of pharmaceuticalsfor use in consultancy in relation to scientific research in the field of pharmaceuticalsfor providing medical research and scientific research information in the field of medicine and pharmaceuticalsfor use in drug discovery servicesfor use in drug use discovery servicesfor use in scientific and technological servicesmedical laboratoriesscientific research and design for others in the field of pharmaceuticalsconducting and evaluating clinical trials
Publicações
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/06/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/06/2026
DOCK
ASSIGNED TO EXAMINER
13/05/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
30/04/2026
EX3M
SOU EXTENSION 3 DENIAL LETTER MAILED
29/04/2026
EX3D
SOU EXTENSION 3 DENIAL LETTER PREPARED
29/04/2026
IUAF
USE AMENDMENT FILED
10/03/2026
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2026
EXT3
SOU EXTENSION 3 FILED
09/03/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/01/2026
EX2G
SOU EXTENSION 2 GRANTED
23/01/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
23/01/2026
EEXT
SOU TEAS EXTENSION RECEIVED
03/09/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/09/2025
EXT2
SOU EXTENSION 2 FILED
02/09/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/03/2025
EX1G
SOU EXTENSION 1 GRANTED
10/03/2025
EXT1
SOU EXTENSION 1 FILED
10/03/2025
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/07/2024
PUBO
PUBLISHED FOR OPPOSITION
16/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
29/05/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/05/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
29/05/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/05/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
28/05/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/03/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
13/03/2024
ALIE
ASSIGNED TO LIE
13/03/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/03/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
13/03/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/03/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/03/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
27/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/11/2023
GNRT
NON-FINAL ACTION E-MAILED
16/11/2023
CNRT
NON-FINAL ACTION WRITTEN
16/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2023
GNRT
NON-FINAL ACTION E-MAILED
12/09/2023
CNRT
NON-FINAL ACTION WRITTEN
12/09/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/12/2022
NWAP
NEW APPLICATION ENTERED
03/12/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RECURSION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.